Regression of cardiac involvement by malignant melanoma following lomustine chemotherapy.

Abstract

Cardiac involvement by malignant melanoma is usually a premorbid event. We present a case of presumed cardiac involvement by malignant melanoma with regression following chemotherapy as demonstrated by transoesophageal echocardiography.

Cite this paper

@article{Carpenter1997RegressionOC, title={Regression of cardiac involvement by malignant melanoma following lomustine chemotherapy.}, author={Michael R Carpenter and Michael Vassallo and Irene Peat and Alistair Scriven}, journal={Postgraduate medical journal}, year={1997}, volume={73 863}, pages={571-2} }